Patient and Provider perspectives on long acting injectable ART

患者和医疗服务提供者对长效注射 ART 的看法

基本信息

  • 批准号:
    10116481
  • 负责人:
  • 金额:
    $ 61.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-15 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

ABSTRACT Long-acting injectable antiretroviral therapy (LAI ART) is anticipated to be a major advance in the management of HIV infection. However, how this therapeutic innovation will be received among patients and providers remains unclear. At present, there are few data with which to forecast, let alone, plan for incorporation of this innovation in HIV care into practice. Our preliminary studies demonstrate excitement for LAI ART among participants in research trials of this mode of ART administration, with possibly less enthusiasm among HIV care providers. With the proposed research studies, we seek to gain a deeper understanding of the perceptions regarding LAI ART among diverse groups of PLHIV in the US and their care providers. This understanding will be used to inform the roll-out of LAI ART, including the development of tools that PLHIV and providers can use to guide shared decision-making when choosing among treatment options.
摘要 长效可注射抗逆转录病毒疗法(LAIART)预计将是治疗艾滋病的一个重大进展。 艾滋病毒感染的管理。然而,这种治疗创新将如何在患者中得到接受, 供应商仍然不清楚。目前,几乎没有什么数据可以用来预测,更不用说计划合并了 将这一艾滋病护理创新付诸实践。我们的初步研究表明, 参与这种ART管理模式的研究试验的参与者, 提供商通过拟议的研究,我们寻求更深入地了解人们的看法, 在美国不同的艾滋病病毒感染者群体及其护理提供者中,这种理解将 用于为LAI ART的推出提供信息,包括开发艾滋病毒感染者和提供者可以使用的工具 在选择治疗方案时指导共同决策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLARE L BARRINGTON其他文献

CLARE L BARRINGTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLARE L BARRINGTON', 18)}}的其他基金

Understanding burden and lived experience of diabetes and hypertension among women living with HIV in the Dominican Republic to improve care integration
了解多米尼加共和国艾滋病毒感染者的糖尿病和高血压负担和生活经历,以改善护理一体化
  • 批准号:
    10538201
  • 财政年份:
    2022
  • 资助金额:
    $ 61.19万
  • 项目类别:
Understanding burden and lived experience of diabetes and hypertension among women living with HIV in the Dominican Republic to improve care integration
了解多米尼加共和国艾滋病毒感染者的糖尿病和高血压负担和生活经历,以改善护理一体化
  • 批准号:
    10653263
  • 财政年份:
    2022
  • 资助金额:
    $ 61.19万
  • 项目类别:
Piloting a multi-level intervention to promote viral suppression among transgender women living with HIV
试点多层次干预措施,促进感染艾滋病毒的跨性别女性的病毒抑制
  • 批准号:
    10676883
  • 财政年份:
    2022
  • 资助金额:
    $ 61.19万
  • 项目类别:
Piloting a multi-level intervention to promote viral suppression among transgender women living with HIV
试点多层次干预措施,促进感染艾滋病毒的跨性别女性的病毒抑制
  • 批准号:
    10548552
  • 财政年份:
    2022
  • 资助金额:
    $ 61.19万
  • 项目类别:
PrEP Up!: Understanding PrEP stigma to improve uptake among men who have sex with men
PrEP Up!:了解 PrEP 耻辱以提高男男性行为者的接受度
  • 批准号:
    9914144
  • 财政年份:
    2019
  • 资助金额:
    $ 61.19万
  • 项目类别:
PrEP Up!: Understanding PrEP stigma to improve uptake among men who have sex with men
PrEP Up!:了解 PrEP 耻辱以提高男男性行为者的接受度
  • 批准号:
    9754300
  • 财政年份:
    2019
  • 资助金额:
    $ 61.19万
  • 项目类别:
Patient and Provider perspectives on long acting injectable ART
患者和医疗服务提供者对长效注射 ART 的看法
  • 批准号:
    10589878
  • 财政年份:
    2019
  • 资助金额:
    $ 61.19万
  • 项目类别:
Patient and Provider perspectives on long acting injectable ART
患者和医疗服务提供者对长效注射 ART 的看法
  • 批准号:
    10437594
  • 财政年份:
    2019
  • 资助金额:
    $ 61.19万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 61.19万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了